PlainRecalls

OriGen Biomedical, Inc.

Compiled from official public sources by the editorial team.

19 recalls on record · Latest: Feb 21, 2024

OriGen Biomedical, Inc. Recall Insight

OriGen Biomedical, Inc. appears on 19 federal recall records indexed by PlainRecalls, out of 101,704 total recalls tracked across the FDA, CPSC, and NHTSA. That represents approximately 0.019% of the federal archive, a data point that is only interpretable alongside production volume, product mix, and decades of operation, because a high recall count alone does not establish fault. Large, diversified firms that sell tens of millions of units across many categories will mechanically accumulate more recall records than small manufacturers, even when their defect rates per unit shipped are comparable or lower. The most recent action on this firm is dated Feb 21, 2024, which is the anchor point for assessing whether enforcement is currently active or historical.

On this page of 19 entries, severity tagging shows 9 critical, 9 moderate, and 1 lower-severity recalls. Affected-unit counts are disclosed on 19 of 19 entries, unit-count disclosure is more common on CPSC and NHTSA actions and less common on FDA drug/device recalls, where lot numbers and distribution scope substitute for absolute totals. The records on this page span 1 distinct product categories, with issuing agencies dominated by FDA Devices (19). The date window on this page runs from Apr 29, 2015 to Feb 21, 2024.

Manufacturer-level browsing is useful when monitoring a single firm for patterns, whether recalls cluster around one product family (suggesting a specific design or supplier issue) or scatter across the firm's entire catalog (which can indicate systemic quality-control problems or deliberate regulator attention). Clicking into each recall reveals the specific hazard, remedy, and distribution scope that together determine whether a consumer is actually at risk. For decisions that depend on being current, deciding whether a product in your home is safe, whether to return a gift, or whether to accept a replacement, always verify the recall number on the issuing agency's site, because federal agencies amend, terminate, and re-scope recalls over time and only the agency's live record reflects the current legal status. This page aggregates what agencies have published publicly and is intended for consumer awareness and research.

FDA Devices Moderate Feb 21, 2024

Accessory Sets Syringes: 6ml syringe with a female luer with 15cm sealed SCD tubing, REF: RF-T15, and 60ml syringe on a female luer with 15cm sealed …

FDA Devices Low Apr 21, 2021

Evolve Cell Culture Bags, part numbers: EV1000N and EV3000N The Evolve bag is made of Ethyl Vinyl Olefin (EVO) and contains no BPA or latex. The …

FDA Devices Moderate Nov 11, 2020

3/8" FloPump, 32mL, (Sterile), REF 6400S, UDI: (01) 081432102013 1, Sterile EO, Rx Only

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV28F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV19F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV13F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV23F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV32F

FDA Devices Critical Jun 12, 2019

ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV16F

FDA Devices Critical Nov 14, 2018

REF VV19F Reinforced Dual Lumen Cannula, 19Fr., Sterile EO, DISPOSABLE: DO NOT RE-USE CE 0473 Product Usage: The OriGen RDLC catheter is indicat…

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 32Fr., REF: VV32F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a sing…

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 16Fr., REF: VV16F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a singl…

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO; and ECMO Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO Indications: …

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 23Fr., REF: VV23F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a singl…

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO; and ECMO Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO

FDA Devices Moderate Oct 24, 2018

ECMO Reinforced Dual Lumen Cannula, 28Fr., REF: VV28F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a …

FDA Devices Moderate Oct 24, 2018

Reinforced Dual Lumen Cannula, 19Fr., REF: VV19F, Sterile EO Indications: The OriGen Reinforced Dual Lumen Cannula is indicated for use as a sing…

FDA Devices Critical Nov 1, 2017

The OriGen Reinforced Dual Lumen catheter (RDLC) is a duel lumen catheter with a wire reinforcement layer on the tip of the device. A thin sheath is …

FDA Devices Critical Apr 29, 2015

OriGen BIOMEDICAL VV13F Reinforced Dual Lumen Catheter STERILE DISPOSABLE: DO NOT RE-USE Manufactured by: OriGen Biomedical. OriGene VV13F Rein…

Nearby Manufacturers

Other firms with recall activity tracked in the PlainRecalls index.

Compare OriGen Biomedical, Inc. with Zimmer Biomet, Inc. →

Data Sources

  • Source: FDA + CPSC + NHTSA - federal recall filings naming this firm. Verify with FDA, CPSC, or NHTSA directly.
  • Source: PlainRecalls Manufacturer Index - firm-level aggregation across all three federal recall feeds

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Recalls are aggregated across FDA, CPSC and NHTSA filings that name this firm; the total reflects the federal record, not an independent investigation. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.